(株)免疫生物研究所企業情報
主市場 | 業種 | 証券コード/EDINET | 英名称 | 発行済み株式数 | 単元 |
---|---|---|---|---|---|
東証GRT | 医薬品 | 4570/E00986 | Immuno-Biological Laboratories Co.,Ltd. | 9,314,590株 | 100株 |
機関の空売り残高情報
計算日 | 空売り者 | 残高割合 | 増減率 | 残高数量 | 増減量 | 備考 |
---|---|---|---|---|---|---|
2018/09/03 | UBS AG | 0.730% | -0.080% | 62,000株 | -7,000 | |
2018/08/31 | UBS AG | 0.810% | -0.020% | 69,000株 | -1,400 | |
2018/08/30 | UBS AG | 0.830% | -0.040% | 70,400株 | -3,300 | |
2018/08/29 | UBS AG | 0.870% | -0.030% | 73,700株 | -2,400 | |
2018/08/27 | UBS AG | 0.900% | -0.040% | 76,100株 | -3,200 | |
2018/08/24 | UBS AG | 0.940% | -0.060% | 79,300株 | -5,400 | |
2018/08/23 | UBS AG | 1.000% | -0.060% | 84,700株 | -5,000 | |
2018/08/22 | UBS AG | 1.060% | -0.010% | 89,700株 | -1,200 | |
2018/08/20 | UBS AG | 1.070% | -0.030% | 90,900株 | -1,900 | |
2018/08/17 | UBS AG | 1.100% | -0.060% | 92,800株 | -5,200 | |
2018/08/16 | UBS AG | 1.160% | -0.040% | 98,000株 | -3,500 | |
2018/08/15 | UBS AG | 1.200% | -0.020% | 101,500株 | -1,400 | |
2018/08/10 | UBS AG | 1.220% | -0.010% | 102,900株 | -800 | |
2018/08/08 | UBS AG | 1.230% | -0.080% | 103,700株 | -6,800 | |
2018/07/26 | UBS AG | 1.310% | +0.030% | 110,500株 | +2,700 | |
2018/07/24 | UBS AG | 1.280% | +0.020% | 107,800株 | +1,500 | |
2018/07/23 | UBS AG | 1.260% | +0.090% | 106,300株 | +7,000 | |
2018/07/17 | UBS AG | 1.170% | +0.010% | 99,300株 | +1,000 | |
2018/07/13 | UBS AG | 1.160% | +0.050% | 98,300株 | +4,500 | |
2018/07/12 | UBS AG | 1.110% | +0.040% | 93,800株 | +3,000 | |
2018/07/10 | UBS AG | 1.070% | +0.060% | 90,800株 | +5,500 | |
2018/07/09 | UBS AG | 1.010% | +0.390% | 85,300株 | +32,300 | |
2018/07/06 | UBS AG | 0.620% | -0.010% | 53,000株 | -300 | |
2018/07/05 | UBS AG | 0.630% | +0.110% | 53,300株 | +8,800 | |
2018/07/04 | UBS AG | 0.520% | 0% | 44,500株 |